Subscribe
Sign in
Subscribe
Sign in
GlobalData
GlobalData

Sarath.Chandra@globaldata.com

  • Home
  • Author: Sarath.Chandra@globaldata.com

Despite positive efficacy data highlighted at AAN 2024, Axsome Therapeutic’s ASX-07 will struggle to make significant impact in acute migraine market, says GlobalData

Following a poster presentation at the American Academy of Neurology (AAN) 2024 annual meeting of new pooled data from two Phase III trials, MOMENTUM (NCT0389600) and INTRCEPT (NCT04163185), evaluating Axsome Therapeutics’s AXS-07 (MoSEIC™ meloxicam and rizatriptan) as a novel acute combination treatment for migraine; Philippa Salter, Senior Neurology Analyst at GlobalData, a leading data and […]
Read more

Elahere and Keytruda pave way to ADC and ICI strategies in endometrial cancer, says GlobalData

At the recently held 2024 American Association for Cancer Research (AACR) Annual Meeting, positive Phase II trial results of the combination of Immunogen’s antibody-drug conjugate (ADC) Elahere and Merck & Co’s immune checkpoint inhibitor (ICI) Keytruda in the treatment of folate receptor-alpha (FR-α) positive recurrent microsatellite stable / mismatch repair proficient serous endometrial cancer were […]
Read more

Comcast takes a big, timely swing at holistic prepaid connectivity with NOW brand launch, says GlobalData

Following the news that Comcast is launching a portfolio of low-cost prepaid internet, mobile, and pay-TV services under the “NOW” brand umbrella in the US; Charles Garrett, Principal Global Telecom Consumer Services Analyst at GlobalData, a leading data and analytics company, offers his view: “With the fixed wireless access (FWA) challengers sucking up much of […]
Read more

MASH innovator drug partnerships surge over $2.5 billion in 2024YTD, reveals GlobalData

Biopharmaceutical companies are regaining interest in metabolic dysfunction-associated steatohepatitis (MASH) innovator drug development. MASH innovator drugs witnessed over $2.5 billion increase in the total value of partnership deals from 2020 to 2024 year-to-date (YTD), with more than $2 billion forged in Q1 2024 alone, reveals GlobalData, a leading data and analytics company. MASH, previously known […]
Read more

Semiconductor chips drive innovation in AI and industries, says GlobalData

Semiconductor chips are driving a transformative wave across technology, healthcare, automotive, telecom, and power industries. These chips, particularly those fueling AI capabilities, are fundamentally reshaping industries, ushering in a new era of innovation and efficiency gains, according to GlobalData, a leading data and analytics company. Kiran Raj, Practice Head of Disruptive Tech at GlobalData, comments: […]
Read more

Boeing P-8A aircraft contract bolsters Australia maritime defense amid rising regional tensions, says GlobalData

Following the news that Boeing has been awarded a contract to deliver software, systems and sensor upgrades to enhance the anti-submarine warfare, maritime strike and intelligence collection capabilities of the Royal Australian Airforce’s (RAAF) P-8A Poseidon maritime patrol aircraft; Akash Pratim Debbarma, Defense Analyst at GlobalData, a leading data and analytics company, offers his view: […]
Read more

Physicians lack consensus on patient choice between branded and generic drugs, finds GlobalData

Generic drugs present a notable absence of consensus among physicians within the realm of healthcare regarding patients’ choice between branded and generic alternatives. This lack of a clear stance among healthcare providers prompts an in-depth investigation into the myriad factors shaping their perspectives, including efficacy, patient preferences, and cost considerations. Understanding these dynamics is pivotal […]
Read more

Regulatory oversight crucial as mHealth apps transform healthcare delivery, says GlobalData

Mobile health (mHealth) applications have emerged as powerful tools in transforming healthcare delivery and empowering individuals to take charge of their well-being. These apps, when regulated effectively, not only enhance patient outcomes but also contribute significantly to the efficiency and accessibility of healthcare services. With the increasing adoption of mHealth apps, regulatory frameworks play a […]
Read more

Arrowhead Pharmaceuticals plozarsiran holds potential to treat dyslipidemia, says GlobalData

Arrowhead Pharmaceuticals has recently unveiled final data from its Phase II SHASTA-2 clinical trial for plozasiran, previously recognized as ARO-APOC3. The data indicates a substantial reduction in Apolipoprotein C-III (APOC3) and triglycerides by as much as 86% and 90%, respectively. Should it secure approval, plozasiran holds potential to effectively address critical unmet needs in dyslipidemia […]
Read more

Positive momentum for Google Workspace continues, finds GlobalData

The recent Google Cloud Next ‘24 event showcased an array of enhancements to Google Workspace, including innovative AI-powered features like Vertex AI and Google Vids. These additions aim to bolster team collaboration and productivity. Despite the competition’s strides in AI integration, Google’s introduction of “Gemini for Google Workspace” sets it apart, says GlobalData, a leading […]
Read more

Unlocking corporate resilience: Join GlobalData webinar on net zero strategies

As the landscape of environmental, social, and governance (ESG) considerations continues to evolve, businesses worldwide are confronting the imperative of decarbonization. The looming specter of climate change has catalyzed a seismic shift across industries, compelling corporations to recalibrate their operations towards “net zero” emissions. As regulatory, investor, and consumer pressures intensify, the pursuit of sustainability […]
Read more

Smiths Medical ventilator recall to give rise to competitor growth opportunities, says GlobalData

Smiths Medical’s recall of more than 2,900 emergency ventilators has reverberated throughout the transport ventilator market. Concerns regarding device reliability and safety have prompted healthcare providers to reassess their options considering the critical need for dependable equipment. This development presents an opportunity for competitors like Philips and GE Healthcare to potentially reshape the landscape of […]
Read more

Apple bends to Right to Repair movement, says GlobalData

Following the news on 11 April 2024 that Apple will support repairs with used Apple parts that will not compromise users’ safety, security or privacy; Anisha Bhatia, Senior Technology Analyst at GlobalData, a leading data and analytics company, offers her view: “Apple’s enhancement of its repair process to utilize used Apple parts is a win […]
Read more

Nanoscope Therapeutics MCO-010 poses looming challenge to Spark Therapeutics Luxturna in retinitis market, says GlobalData

Nanoscope Therapeutics’ gene therapy MCO-010 (sonpiretigene isteparvovec) is in the spotlight with encouraging Phase IIb results from its RESTORE trial (NCT04945772) in the retinitis pigmentosa (retinitis) market. Offering a new mechanism of action, it presents a looming challenge to Spark Therapeutics’ Luxturna (voretigene neparvovec-rzyl), the current frontrunner in gene therapy for retinitis. With promising safety […]
Read more

Geopolitics defining theme of decade, as global business landscape faces challenges, says GlobalData

Geopolitics has emerged as a defining theme over the past decade, reshaping global dynamics and leaving a profound impact on economies and international relations. Geopolitical turbulence has created a landscape fraught with uncertainty for multinational corporations. As tensions escalate in regions like the Middle East and Ukraine, navigating the intricate interplay of economic, political, and […]
Read more

CRISPR-based innovations drive $21 billion in pharmaceutical licensing deals over five years, reveals GlobalData

The pharmaceutical industry has experienced a notable uptick in licensing agreements for innovator drugs incorporating clustered regularly interspaced short palindromic repeats (CRISPR)-based technology over the past five years. These agreements, primarily concentrated in oncology, immunology, and central nervous system therapeutics, have collectively accumulated an impressive $21 billion in deal value. Furthermore, the period from 2020 to […]
Read more

AR improves productivity and efficiency in agriculture, but adoption remains limited, says GlobalData

The application of augmented reality (AR) technology is disrupting multiple industries with real-life use cases. The hands-free data visualization provided by AR not only improves productivity throughout the agribusiness value chain but also increases the efficiency and efficacy of training in agriculture, using simulations or real-time direction. Against this backdrop, businesses will continue to adopt […]
Read more
1 … 68 69 70 71 72 … 209